Der Einfluß von Taprosten auf Thrombozyten-aktivierung und klinischen Verlauf nach perkutaner transluminaler Angioplastie

Vasa - Journal of Vascular Diseases

Volumn 25, Issue 1, 1996, Pages 65-72

  Heinz, M ^a,d   Theiss, W ^a   Van Flierut, E D E ^b   Sohngen M ^c  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c GRÜNENTHAL GMBH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; DIPYRIDAMOLE; INDIUM 111; PROSTACYCLIN; TAPROSTENE;

ADULT; AGED; ANGIOPLASTY; ARTERY OCCLUSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; FEMORAL ARTERY; HUMAN; ORAL DRUG ADMINISTRATION; THROMBOCYTE ACTIVATION;

ADMINISTRATION, ORAL; ADULT; AGED; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; ASPIRIN; CARDIOVASCULAR AGENTS; DIPYRIDAMOLE; DRUG THERAPY, COMBINATION; EPOPROSTENOL; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PILOT PROJECTS; PLATELET ACTIVATION; RECURRENCE; TREATMENT OUTCOME;

EID: 3142562498     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. AMENDT K, HSU E, JANSEN T, WEISS T, DIEHM C, FRINGS M, SÖHNGEN W. Taprosten im Vergleich zu Pentoxifyllin bei Patienten mit peripherer arterieller Verschlußkrankheit (PAVK) Stadium IIb - eine randomisierte Doppelblindstudie. VASA 1993; 41 (Suppl.): 37.
2. - [2] BAUMGARTNER I, SCHALCH I, BOLLINGER A. Doppelblindstudie zur Wirkung von Dipyridamol bei Patienten mit Claudicatio intermittens. VASA 1992; 21: 387-91.
3. - [3] COX JL, GOTLIEB AI. Review of antiplatelet drug use in preventing restenosis following percutaneous transluminal coronary angioplasty. Can J Cardiol 1988; 4: 201-10.
4. - [4] EL GAMAL BA, PFLIEGLER G, CRAWFORD N. Effect of platelet encapsulated Iloprost on platelet aggregation and adhesion to collagen and injured blood vessels in vitro Thromb Haemost 1992; 68: 606-14.
5. - [5] FISCHELL TA, NELLESSEN U, JOHNSON DE, GINSBURG R. Endothelium-dependent arterial vasoconstriction after balloon angioplasty. Circulation 1989; 79: 899-910.
6. - [6] FITSCHA P, KALIMAN J. O'GRADY J, SINZINGER H. In vivo modulation of platelet deposition on human atherosclerotic lesions by various antiaggregatory prostaglandins. Folia Haematol Int Mag Klin Morphol Blutforsch 1988; 115: 443-6.
7. - [7] FRINGS M, GEBHARDT H, BARTH H, SÖHNGEN W. Wirksamkeit von Taprosten in den europäischen PARTNER Studien. VASA 1993; 41 (Suppl.): 48.
8. - [8] HINDERER S, BRACHMANN R, NEDDER KH, BUCHER J, BEISCHER W. Einsatz von Prostaglandin E1 bei Diabetikern und Nicht-Diabetikern mit schwerer arterieller Verschlußkrankheit im Stadium IIb-IV nach Fontaine. VASA 1991; 20: 100-8.
9. - [9] HÖFLING B, GONSCHIOR P, NIKOL S, BAURIEDEL G, WELSCH U, NERLICH A. Pathophysiologie und Pathobiopsie der Rezidivstenose. Z Kardiol 1994; 83: 313-8.
10. HOMBACH V, WALTENBERGER J, VOISARD R, HÖHER M, Rezidivstenose nach Koronarangioplastie. Z Kardiol 1995; 84: 5-21.
11. - [11] HSU E, AMENDT K, WEISS T, WILHELM C, DIEHM C, FRINGS M, KIESE B, SÖHNGEN W. Taprosten im Vergleich zu Pentoxifyllin bei Patienten mit peripherer arterieller Verschlußkrankheit (PAVK) Stadium IV - eine randomisierte Doppelblindstudie. VASA 1993; 41 (Suppl.): 49.
12. - [12] JANICEK MJ, VAN DEN ABBEELE AD, HOLLENBERG NK, KASSIS AI, HOLMAN BL, TUMEH SS. Platelet activation and aggregation after endothelial injury. Assessment with indium-111-labeled platelets and angiography. Invest Radiol 1990; 25: 988-93.
13. - [13] JOHNSON G 3d, FURLAN LE, AOKI N, LEFER AM. Endothelium and myocardial protecting actions of taprostene, a stable prostacyclin analogue, after acute myocardial ischemia and reperfusion in cats. Circ Res 1990; 66: 1362-70.
14. - [14] KISHI Y, NUMANO F. In vitro study of vascular endothelial injury by activated platelets and its prevention. Atheroscleroris 1989; 76: 95-101.
15. - [15] KYRLE PA, EICHLER HG, JAGER U, LECHNER K. Inhibition of prostacyclin and thromboxane A2 generation by low dose aspirin at the site of plug formation in man in vivo. Circulation 1987; 75: 1025-9.
16. - [16] LETZEL H, SCHOOP W. Gingko-biloba-Extrakt EGb 761 und Pentoxifyllin bei Claudication intermittens. Sekundaranalyse zur klinischen Wirksamkeit. VASA 1992; 21: 403-10.
17. - [17] MATTSSON E, BRUNKWALL J, FALT K, BERGQVIST D. Prostanoid release immediately after balloon angioplasty in three models of atherosclerosis in rabbits. Eur J Surg 1993; 159: 15-21.
18. - [18] MICHEL G, SEIPP U. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting. Arzneimittelforschung 1990; 40: 932-8.
19. - [19] MINAR E, EHRINGER H, AHMADI R, DUDCZAK R, LEITHA T, KOPPENSTEINER R, JUNG M, STUMPFLEN A. Platelet deposition at angioplasty sites and its relation to restenosis in human iliac and femoropopliteal arteries. Radiology 1989; 170: 767-72.
20. - [20] MINAR E, EHRINGER H, DUDCZAK R, SCHOFL R, JUNG M, KOPPENSTEINER R, AHMADI R, KRETSCHMER G. Indium-111-labeled platelet scintigraphy in carotid atherosclerosis. Stroke 1989; 20: 27-33. -
21. PLATE G, STANSON AW, HOLLIER LH, DEWANJEE MK, SOLIS E, KAYE MP. Effect of platelet inhibitors on platelet and fibrin deposition following transluminal angioplasty of the atherosclerotic rabbit aorta. Eur J Vasc Surg 1989; 3: 127-33.
22. - [22] PONGRATZ G, POHLE K, STINGL D, BACHMANN K. Thrombozytenaktivierung und Thrombozytenaggregation am arteriosklerotisch veränderten Endothel. Dtsch Med Wschr 1995; 120: 1009-14.
23. - [23] SINZINGER H, VIRGOLINI I, O'GRADY J. Clinical trials of PGE1, PGI2 and mimetics in patients with peripheral vascular disease. Prog Clin Biol Res 1989; 301: 85-96.
24. - [24] THAKUR ML, WALSH L, MALECH HL, GOTTSCHALK A. Indium-111-labeled human platelets: Improved method, efficacy and evaluation. J Nucl Med 1981; 22: 381-5.
25. - [25] VIRGOLINI I, FlTSCHA P, O'GRADY J, BARTH H, SINZINGER H. Effects of taprostene, a chemically stable prostacyclin analogue, in patients with ischaemic peripheral vascular disease: a placebo controlled double-blind trial. Prostglandins Leukot Essent Fatty Acids 1989; 38: 31-5.
26. - [26] WEICHERT W, MEENTS H, ABT K, LIEB H, HACK W, KRZYWANEK HJ, BREDDIN HK. Acetylsalicylic acid - reocclusion - prophylaxis after angioplasty (ARPA-study). VASA 1994; 23: 57-65.